secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001683168-23-003826
Event type: regulatory
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Received Nasdaq letter on May 30, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Compliance achieved after closing bid price >= $1.00 for 10 consecutive days (May 15-26, 2023).
- Previous deficiency was notified on June 3, 2022; this matter is now closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316823003826/0001683168-23-003826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316823003826/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-003826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer